Studies on the Roles of T Helper Type I and Type II Cytokines in HIV Immunopathogenesis PDF Download

Author: Mohammad Pirouz Daftarian
Publisher:
ISBN:
Category : Cytokines
Languages : en
Pages : 0

View

Book Description

Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :

View

Book Description

Author: Mohammad Pirouz Daftarian
Publisher:
ISBN:
Category : Cytokines
Languages : en
Pages : 316

View

Book Description

Author: Anthony S. Fauci
Publisher: Springer Science & Business Media
ISBN: 3642608671
Category : Medical
Languages : en
Pages : 159

View

Book Description
During the last 5 years, major advances have been made in our understanding of the pathogenesis of human immunodeficiency virus (HIV) disease and in the development of new potent antiviral agents. With regard to HIV pathogenesis, several recent observations have not only changed our perspectives of HIV disease, but have been critical for the design of therapeutic strategies.

Author: Constantinos Petrovas
Publisher: Frontiers Media SA
ISBN: 2889457583
Category :
Languages : en
Pages : 186

View

Book Description
Currently, more than 36 million people are infected with HIV. Although the introduction of highly active anti-retroviral therapy (HAART) has led to substantial advances in the clinical management of HIV infected individuals, HAART cannot completely eliminate the virus. This is because CD4 T helper cells, harboring the virus, remain dormant reservoirs. These reservoirs are difficult to measure and are present even in HAART-treated HIV infected individuals with undetectable levels of HIV in the blood. A growing body of studies has revealed follicular helper (Tfh) CD4 T cells, a highly differentiated CD4 T cell population localized in immunologically sanctuary sites (follicle/germinal center), as a major reservoir of HIV. The present Frontiers in Immunology eBook compiles 16 timely review articles focusing on the dynamics of major follicular immune cell types in HIV/SIV infection and their potential role for disease pathogenesis and the viral persistence in the lymph node. This eBook provides a comprehensive presentation of recent published work on lymph node and especially Tfh cell dynamics in HIV infection and we hope that it will be useful for our further understanding of how such dynamics affect the interplay between virus and host as well as for the discovery of novel therapeutic targets in the fight against HIV.

Author: Sudhir Gupta
Publisher: Springer Science & Business Media
ISBN: 1489901914
Category : Medical
Languages : en
Pages : 618

View

Book Description
Leading experts provide the only comprehensive book examining all aspects of immune response and immune-based treatments for HIV infection. Contributions, divided into three sections, discuss basic mechanisms, immunopathogenesis of HIV infection, and immune-based therapies. Researchers thoroughly review vaccine-including prospects of T cell vaccine-and gene therapy for HIV infection. Additional topics include organization of HIV genes, the role of co-receptors in signaling of lymphocytes, and biological response modifiers. This reference is designed for basic and clinical researchers, internists, pediatricians, infectious disease specialists, neuropathologists, oncologists, and rheumatologists.

Author: P. Miossec
Publisher: Springer Science & Business Media
ISBN: 9783764358532
Category : Medical
Languages : en
Pages : 256

View

Book Description
Rheumatoid arthritis (RA) is the most common and most severe form of inflammatory arthritis. The pathogenesis of RA has been the subject of intense research for several decades. The prevailing hypotheses have changed over the years, and have attempted to incorporate the most recent data. Although T cells represent an important component of the cells which infiltrate the joint synovium, their contribution at a late stage of the disease remains a matter of debate. The goal of this book is to outline the major arguments and data suggesting that T cells may, or may not, be central players in the pathogenesis of chronic RA. While each of the editors and authors has his/her own bias (as will be clear by reading the respective chapters), our hope is that the readers will enjoy a complete and balanced view of the critical questions and experiments. This is not just an intellectual exercise since the direction of future therapeutic interventions depends heavily on how one interprets the pathogenesis of RA and the contribution of T cells.

Author: Chi-Him Pong
Publisher:
ISBN: 9781361362266
Category :
Languages : en
Pages :

View

Book Description
This dissertation, "HIV-1 Tat Induced Immune Responses and Its Effect on Opportunistic Infections" by Chi-him, Pong, 龐智謙, was obtained from The University of Hong Kong (Pokfulam, Hong Kong) and is being sold pursuant to Creative Commons: Attribution 3.0 Hong Kong License. The content of this dissertation has not been altered in any way. We have altered the formatting in order to facilitate the ease of printing and reading of the dissertation. All rights not granted by the above license are retained by the author. Abstract: Acquired immunodeficiency syndrome (AIDS) is a major problem in our current society. There are over 35 million of the population that are currently living with human immunodeficiency virus (HIV), and the number of HIV-infected patients are still rising every year in spite of our efforts to control it. Furthermore, within the AIDS affected population, opportunistic infection is a major cause of complications and is the number one cause of death. The HIV trans-activator (Tat) protein plays a major role in the AIDS pathogenesis. HIV-1 Tat is known to cause dysregulation of cytokines such as TNF-α, IL-6, and IL-10 in AIDS patients. In this study we recognized a proto-oncogene, c-Myc, could regulate the cytokine dysregulation caused by HIV-1 Tat in primary blood monocyte derived macrophages (PBMac). By knocking down the expression of c-Myc with gene specific small-interfering RNA (siRNA), we demonstrated that c-Myc may be critical for the expression of the pro-inflammatory cytokines TNF-α and IL-6. HIV-1 Tat was subsequently found to regulate the expression of c-Myc via the activation of dsRNA-activated protein kinase (PKR), ERK1/2 and p38 mitogen-activated protein kinase (MAPK). Furthermore, c-Myc regulation of the pro-inflammatory cytokines was demonstrated to have a role in AIDS related opportunistic infections. HIV-1 Tat was shown to increase the intracellular growth of Mycobacteria avium complex (MAC) within PBMac. This increase in MAC growth was in turn found to be regulated by TNF-α expression controlled by c-Myc. HIV-1 Tat was also demonstrated to induce the expression of RIG-I, a common pattern recognition receptor of double stranded RNA viruses, in PBMac. RIG-I is known to activate the viral immune responses such as the type-I interferon (IFN) and pro-inflammatory cytokine pathways. This induction of RIG-I by HIV-1 Tat was found to be regulated by c-Myc, as well as through other signalling kinases such as p38 MAPK and PKR. Tat induction of RIG-I ultimately led to the induction of IFN-α2 and IFN-β through the expression and nuclear translocation of the interferon regulatory factor-7 (IRF-7). This alteration in type-I IFN expression regulated by HIV-1 Tat and RIG-I was also found to play a role against AIDS related opportunistic infections. HIV-1 Tat is known to increase the infectivity of Kaposi's sarcoma-related herpesvirus (KSHV), a common opportunistic viral infection. We were able to demonstrate that this increase in KSHV infectivity was regulated by RIG-I and type-I IFN induced by HIV-1 Tat. Lastly, this study also demonstrated how HIV-1 Tat was able to manipulate the expression of IL-8 induced by KSHV in PBMac. HIV-1 Tat was able to mediate the production of IL-8 induced by KSHV by altering the phosphorylation of the p38 MAPK and the signal transducer and activator of transcription-1 (STAT-1). Taken together, the results of this study showed how c-Myc and RIG-I may be able to play critical roles in HIV-1 Tat induced cytokine dysregulation. Furthermore, the importance of these pathways is further demonstrated in their roles in regulating the immune responses against opportunistic infections in AIDS patients. DOI: 10.5353/th_b5334861 Subjects: HIV infections Viral proteins

Author: Benjamin Gregory Oliver
Publisher:
ISBN:
Category : AIDS (Disease)
Languages : en
Pages : 450

View

Book Description
[Truncated abstract] Initiation of antiretroviral therapy (ART) in HIV patients may result in the restoration of pathogen-specific immune responses which cause immunopathology. This clinical phenomenon is referred to as immune restoration disease (IRD) and can occur in response to a variety of pathogens. Immune restoration disease associated with Mycobacterium tuberculosis (TB-IRD) is the most common form of IRD and presents as tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS), in which there is a paradoxical worsening of treated tuberculosis (TB) in HIV patients who commence ART while receiving anti-TB therapy. Tuberculosis also presents more frequently during the first three months of ART (ART-associated tuberculosis [ARTTB]) and some cases exhibit an atypical inflammatory response similar to TB-IRIS. This unmasking of unrecognised TB may also be a form of IRD in most, if not all, patients. In the first part of my thesis, I investigated whether assessment of plasma biomarkers may elucidate more about the immunopathogenesis, prediction and diagnosis of TBIRD within a cohort of HIV patients from Cambodia, of whom 15 developed TB-IRIS and 11 developed ART-TB. Levels of cytokines and chemokines important in the immune response against M. tuberculosis were assayed in unstimulated plasma from a whole blood interferon-U+00de (IFN-U+00de) release assay (IGRA). TB-IRIS was associated with perturbations of inflammatory mediators produced by cells of the innate immune system, while ART-TB was associated with elevated levels of IL-18. Using ROC analyses, pre-ART levels of IL-18, CCL2 and CXCL10 were strongly predictive of TBIRIS (Chapter 2). A previous study found that IFN-U+00de responses to purified protein derivative (PPD) and region of difference 1 (RD1) antigens may aid in the prediction and diagnosis of ART-TB. Within the same cohort of patients, I assayed levels of IFN- U+00de-inducible chemokines, CXCL9 and CXCL10, in plasma from whole blood IGRAs cultured with PPD and RD1 antigens (Chapter 3). ART-TB was characterised by elevated responses to PPD and RD1 antigens suggesting that ART-TB is associated with a prominent T cell response against mycobacterial antigens. T cell responses against mycobacterial antigens were less prominent in TB-IRIS. Using ROC analyses, CXCL10 responses to RD1 antigens were shown to be a better predictor of ART-TB than IFN-U+00de responses and may aid in the diagnosis of ART-TB (Chapter 3). I also established that levels of IL-5 and IFN-U+00de in plasma from IGRAS stimulated with phytohaemagglutinin positively correlated suggesting that TB-IRIS and ART-TB are not associated with an imbalance in type 1 and type 2 T helper cytokine responses (Chapter 4). To further examine the role of biomarkers in IRD, I measured plasma levels of pro-inflammatory cytokines and chemokines in HIV patients enrolled into the INITIO study. Within this cohort, high pre-ART levels of CXCL10 were associated with non-viral forms of IRD (Chapter 5)...

Author: Jayashree Ravichandran
Publisher:
ISBN:
Category : Cellular immunity
Languages : en
Pages : 150

View

Book Description
It has been more than three decades since HIV (Human Immunodeficiency virus)1 has been identified as the causative agent of AIDS, but an effective vaccine is still underway. Various vaccine vector delivery systems have been developed to enhance CD8 T cell mediated immunity against HIV-1. In our laboratory, heterologous mucosal systemic HIV-1 poxvirus prime-boost immunization have shown to induce high avidity HIV-specific CD8 T cell with excellent protective immunity. These studies also revealed that mucosal immunization induced lower numbers of IL-4 and IL-13 expressing HIV-specific CD8 T cells compared to pure systemic delivery. Data indicated that the route of immunization can determine the quality or avidity of CD8 T cell immunity and this is mainly governed by Th2 cytokines IL-4 and IL-13. Th17 cells are a newly discovered subset of T cells that specifically produce cytokines IL-17A to F. Various studies have shown that both Th1 and Th2 cytokines negatively regulate IL-17A producing CD4 T cells in order to mediate their effector immune response. As Ranasinghe et al. have shown that IL-4 and IL-13 modulate the quality of CD8 T cells, this study aimed to establish whether the expression of IL-17A by HIV-specific CD8 T cells is dependent on Th2 cytokines IL-4, IL-13 or Th1 cytokine IFN-gamma. Wild type BALBc, IL-4, IL-13 and STAT6 KO mice were prime-boost immunized with control vaccine and the expression of IL-17A in spleen and lung were evaluated. Data indicated that the expression of IL-17A was significantly enhanced in HIV specific CD8 T cells obtained from all KO mice tested compared to WT BALBc control mice. But IFN-gamma did not have any effect on the IL-17A expression. To further investigate these findings and better understand the transcriptional regulation of IL-17A; wild type BALBc, IL-4, IL-13 and STAT6 KO mice were prime-boost immunized with control vaccine and RT-PCR was performed to evaluate the IL-17A regulatory factors in CD8 T cells following HIV-specific peptide stimulation. Data showed that IL-17A, TGF-beta, IL-6 and ROR-gamma t mRNA levels were highly elevated in CD8 T cells obtained from IL-4 KO mice compared to the other groups tested. This data further confirmed that IL-4 played a predominant role in down regulating IL-17A induction, and TGF-beta, IL-6 and ROR-gamma t (not IL-23a) were involved in this regulation. As previous studies in our laboratory have shown that IL-13 can significantly modulate the avidity of HIV-specific CD8 T cells, recently, Ranasinghe et al. have developed a vaccine that can temporarily inhibit IL-13 at the vaccination site. Since, IL-4 and IL-13 have shown to modulate IL-17A expression, in this study, the expression of IL-17A in HIV specific CD8 T cells was also evaluated using control vaccine and novel IL-13 inhibitor vaccine at 3 days, 14 days, 8 weeks and 10 days post-challenge. Data indicated that compared to the control vaccine, IL-13 inhibitor vaccine showed enhanced IL-17A expression by HIV-specific CD8 T cells at 14 days post booster vaccination and following surrogate influenza-HIV mucosal challenge in both spleen and lung. Collectively, the data indicate that out of the two Th2 cytokines, IL-4 mainly regulate the IL-7A expression in HIV-specific CD8 T cells. As IL-4 and IL-13 are involved in regulating the avidity of CTLs, data suggest that IL-17A plays an indirect role in modulating CD8 T cell avidity and protective immunity.